REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) is an enterprise located in Colombia, with the main office in Ariguani. The company operates in the Ambulatory Health Care Services industry. It was established on April 15, 2003. From the latest financial highlights, I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) reported a net sales revenue drop of 67.51% in 2025. Its’ total assets recorded a growth of 59.23%. In, 2025, the company’s net profit margin increased by 20.26%.

Headquarters
Cl 4 4 160 Brr Centro
Ariguani; Magdalena;

Contact Details: Purchase the I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) report to view the information.

Basic Information
Registered Capital:
Purchase the I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) report to view the information.
Financial Auditors:
Purchase the I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) report to view the information.
Incorporation Date:
April 15, 2003
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after I.P.S. Unidad Medica Ariguani Y El Magdalena Limitada (U.M.A.G.) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-67.51%▼
Total Operating Revenue
-67.51%▼
Operating Profit
-21.54%▼
EBITDA
-21.54%▼
Net Profit/Loss for the Period
21.05%▲
Total Assets
59.23%▲
Total Equity
51.25%▲
Operating Profit Margin
18.58%▲
Net Profit Margin
20.26%▲
Return on Equity (ROE)
-2.8%▼
Quick Ratio
-32.14%▼
Cash Ratio
-14.42%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo